Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-26
2011-07-26
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S239000
Reexamination Certificate
active
07985758
ABSTRACT:
Compounds of formula (I) modulate the activity of gamma secretase and hence find use in treatment or prevention of Alzheimer's disease and related conditions.
REFERENCES:
patent: 5561130 (1996-10-01), Seward et al.
patent: 0528495 (1993-02-01), None
patent: 2006/043064 (2006-04-01), None
Kulagowski Janusz Josef
Madin Andrew
Ridgill Mark Peter
Anderson Rebecca
Devlin Gerard M.
Hess Susan L.
Merck Sharp & Dohme Limited
Shterengarts Samantha
LandOfFree
Piperidine derivatives for treatment of Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives for treatment of Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives for treatment of Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2741454